Last updated on November 2019

A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus


Brief description of study

The reason for this study is to see how effective and safe the study drug known as baricitinib is in participants with systemic lupus erythematosus (SLE).

Clinical Study Identifier: NCT03616912

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )
If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service. ( Sign Up )